News

3 Nov 2026

EMA launches framework to support regulatory acceptance of NAMs

The European Medicines Agency (EMA) has published new guidance outlining how developers of NAMs can engage with regulators to support their acceptance in medicines development. The guidance describes the range of interactions available with EMA, from early discussions through the Innovation Task Force to scientific and qualification advice, helping developers demonstrate that NAMs are scientifica…


3 Nov 2026

NC3Rs publishes database to support the use of replacement approaches in regulatory safety assessments

We have launched a database of alternative methods and approaches to help identify opportunities for their use in regulatory safety assessment. This delivers a key part of Commitment 10 of the UK's Government’s strategy on replacing animals in science.

The list is initially being published as an Excel spreadsheet with a consultation period for version 1 open until 22 January 2027.

View the database…


3 Nov 2026

MHRA joins global regulators in call to advance alternatives to animal testing

The Medicines and Healthcare products Regulatory Agency (MHRA) has joined other international regulators in endorsing a joint statement calling for the accelerated development and adoption of alternatives to animal testing. The statement sets out a long-term goal of replacing animal testing throughout the medicines lifecycle and highlights the importance of collaboration to advance scientifically…


30 Oct 2026

New National Research Programme for improved chemical safety

The Federal Council has approved the launch of the National Research Programme "Chemical Safety" (NRP 88). It intends to strengthen the scientific basis for the safe and sustainable use of chemicals.


7 Jul 2026

Post-Doctoral Research Position (80–100%) in Digital & Computational Toxicology

Essential qualifications

Desirable qualifications

We offer you

Joining the SCAHT means becoming part of an internationally recognised centre dedicated to advancing human-relevant toxicology and next generation risk assessment. You will work in a highly interdisciplinary environment at the interface of toxicology, data science and regulatory science, with the opportunity to contribute to the digital transformation of toxicology in Switzerland and Europe.

Application / Contact :

Please submit your application as one PDF with motivation letter and CV including work experience via through the online portal. Applications should be submitted not later than August 16. We kindly ask you to apply exclusively through the online portal. For further information, please consult our website scaht.org or contact our scientific coordinator Dr. Stéphanie Boudon, Email : stephanie.boudon@unibas.ch


7 Jul 2026

Post-Doctoral Research Positon (80–100%) in Digital & Computational Toxicology

The Swiss Center for Applied Human Toxicology (SCAHT), affiliated with the University of Basel, is seeking a highly motivated postdoctoral researcher in digital and computational toxicology to strengthen the SCAHT’s activities in the field of the digital transformation of human and regulatory toxicology, with a view to next-generation risk assessment. We are seeking a scientist with a strong background in toxicology and expertise in computational toxicology, data science, artificial intelligence, and data governance. Ideally, the candidate will have experience in applied sciences or a keen interest in applying their experience to address applied research objectives and challenges. The successful candidate will contribute to the development of innovative digital infrastructures, computational workflows, and AI-based tools designed to support the national and international toxicology community.

Application deadline: August 16, 2026

Contract start date: to be agreed upon


6 Jul 2026

MAS in Toxicology 2026-2028

MAS in Toxicology 2026-2028

An education of excellence to master the risks of tomorrow.

Information and Registration

https://www.unige.ch/formcont/en/courses/mas-toxicology
+41 79 553 59 76


23 Jun 2026

Hybrid course: One Health: Concept, case studies, challenges and implementation

The One Health concept is a holistic approach to improving and sustainably

protecting human, animal and environmental health. It recognises that

human, animal and environmental health are closely linked. In this course, we present policy drivers for implementing the

One Health approach, such as the legal framework and guidelines in

Switzerland, and the EU, particularly in the areas of food safety, …


11 Jun 2026

ECHA scientific committee supports classification of TFA as toxic to reproduction

At its meeting of 1–5 June 2026, the Risk Assessment Committee (RAC) of the European Chemicals Agency (ECHA) concluded that trifluoroacetic acid (TFA) should be classified as Reproductive Toxicity Category 1B (H360Df). This means that TFA may damage the unborn child and may impair fertility. RAC also supported the classification of TFA as a PMT substance (Persistent, Mobile and Toxic) and as vPvM…


1 Jun 2026

Sixth report under Article 117(3) of the REACH Regulation: The use of alternatives to testing on animals for the REACH Regulation

Under REACH, registrants are responsible for collecting and generating information on substances manufactured in, or imported into Europe, above one tonne per year, in order to properly assess the hazards and potential risks. This information is communicated to ECHA through a registration dossier. Information on the REACH registration statistics is regularly updated and made publicly available through the ECHA dissemination website8.

This report examines how registrants have fulfilled REACH information requirements in practice and the analysis draws on information submitted in REACH registration dossiers and provides an overview of:

Options used to address the information requirements This analysis reports the percentage of substances using each option (e.g. experimental test, different types of adaptations, data waiver).

Studies available in the REACH database
This analysis reports the number of experimental studies conducted before and after the adoption of REACH.